# David Liao, M.D. – FDA Inspection, Jan 3, 2024

Source: https://www.keypedia.com/records/fda_inspections/david-liao-md/67be8d66-b0b3-4796-b530-ea478533707e
Source feed: FDA_Inspections

> FDA inspection 1226417 of David Liao, M.D., January 03, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226417
- Company Name: David Liao, M.D.
- Inspection Date: 2024-01-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Officers

- [Investigator](https://www.keypedia.com/people/lan-t-tran/ab9c1008-c03f-425f-ac3c-a569d3e5037c)

Company: https://www.keypedia.com/companies/david-liao-md/9da2c04d-a053-49c6-827b-3d8f6a1f75aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d